Your browser doesn't support javascript.
loading
Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma.
Epstein, Tolly G; Murphy-Berendts, Karen; Liss, Gary M; Bernstein, David I.
  • Epstein TG; Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Allergy Partners of Central Indiana, Indianapolis, Indiana. Electronic address: epsteite@uc.edu.
  • Murphy-Berendts K; Bernstein Clinical Research Center, LLC, Cincinnati, Ohio.
  • Liss GM; Division of Occupational and Environmental Health, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Bernstein DI; Division of Immunology, Allergy, and Rheumatology, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio; Bernstein Clinical Research Center, LLC, Cincinnati, Ohio.
Ann Allergy Asthma Immunol ; 127(1): 64-69.e1, 2021 07.
Article en En | MEDLINE | ID: mdl-33753219
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Alérgenos / Desensibilización Inmunológica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Asma / Alérgenos / Desensibilización Inmunológica Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2021 Tipo del documento: Article